-
Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar
Monday, October 5, 2020
View article
-
Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
Monday, August 24, 2020
View article
-
Medicure Announces Termination of ReDSTM Pro Marketing and Distribution Agreement
Thursday, August 20, 2020
View article
-
Medicure Reports Financial Results for Quarter Ended June 30, 2020
Tuesday, August 11, 2020
View article
-
Medicure Q2 2020 Results and Conference Call Dates
Wednesday, August 5, 2020
View article
-
Medicure Announces Normal Course Issuer Bid
Monday, June 29, 2020
View article
-
Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation
Monday, June 29, 2020
View article
-
Medicure Announces a Direct to Patient Online Pharmacy Program for Distribution of ZYPITAMAG™ (Pitavastatin) Tablets
Thursday, June 25, 2020
View article
-
Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020
Monday, June 15, 2020
View article
-
Medicure Reports Financial Results for Quarter Ended March 31, 2020
Tuesday, May 12, 2020
View article
-
Medicure Q1 2020 results and conference call dates
Wednesday, May 6, 2020
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019
Wednesday, April 15, 2020
View article
-
Medicure To Announce Fiscal Year End 2019 Financial Results on April 15, 2020
Monday, April 13, 2020
View article
-
Medicure Announces Preliminary Results of Substantial Issuer Bid
Friday, December 20, 2019
View article
-
Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
Tuesday, December 17, 2019
View article
-
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Thursday, December 12, 2019
View article
-
Medicure Announces Settlement of Holdback Dispute from Apicore Sale
Thursday, December 5, 2019
View article
-
Medicure Files Patent Infringement Action
Thursday, December 5, 2019
View article
-
Medicure Reports Financial Results for Quarter Ended September 30, 2019
Tuesday, November 26, 2019
View article
-
Medicure Q3 2019 Results and Conference Call Dates
Tuesday, November 19, 2019
View article
-
Medicure Announces Commencement of Substantial Issuer Bid
Wednesday, November 13, 2019
View article
-
Medicure Announces Intention to Commence Substantial Issuer Bid
Monday, November 4, 2019
View article
-
Medicure Announces SMILE™-HF Study Demonstrates Use of ReDS™ Results in 58% Reduction in Hospital Readmission Rate
Tuesday, October 15, 2019
View article
-
Medicure Announces Preferred Pricing Agreement for Zypitamag™ with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force
Thursday, October 3, 2019
View article
-
Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag™
Monday, September 30, 2019
View article
-
Medicure Announces Launch of New and Improved ReDS™ PRO
Tuesday, September 17, 2019
View article
-
Medicure Announces Settlement of Patent Infringement Action
Wednesday, August 21, 2019
View article
-
Medicure Reports Financial Results for Quarter Ended June 30, 2019
Thursday, August 8, 2019
View article
-
Medicure Q2 2019 Results and Conference Call Dates
Friday, August 2, 2019
View article
-
Medicure Announces Results of 2019 Annual Meeting of Shareholders
Wednesday, June 26, 2019
View article
-
Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer
Monday, June 10, 2019
View article
-
Medicure Announces Renewal of its Normal Course Issuer Bid
Thursday, May 30, 2019
View article
-
Medicure Reports Financial Results for Quarter Ended March 31, 2019
Monday, May 27, 2019
View article
-
Medicure Q1 2019 Results and Conference Call Dates
Wednesday, May 22, 2019
View article
-
Medicure Appoints Ms. Manon Harvey to its Board of Directors
Wednesday, May 15, 2019
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018
Monday, April 29, 2019
View article
-
Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019
Wednesday, April 24, 2019
View article
-
Medicure Provides Update on Release of Holdback Funds from Apicore Sale
Wednesday, February 13, 2019
View article
-
Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States
Monday, January 28, 2019
View article
-
Medicure reports financial results for quarter ended September 30, 2018
Tuesday, November 20, 2018
View article
-
Medicure Files Patent Infringement Action
Friday, November 16, 2018
View article
-
Medicure Q3 2018 Results and Conference Call Dates
Wednesday, November 14, 2018
View article
-
Medicure Reports Financial Results for Quarter Ended June 30, 2018
Wednesday, August 15, 2018
View article
-
Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection
Monday, August 13, 2018
View article
-
Medicure Q2 2018 Results and Conference Call Dates
Wednesday, August 8, 2018
View article
-
Medicure Reports Financial Results for Quarter Ended March 31, 2018
Wednesday, May 23, 2018
View article
-
Medicure Q1 2018 Results and Conference Call Dates
Thursday, May 17, 2018
View article
-
Medicure Announces Normal Course Issuer Bid
Thursday, May 17, 2018
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017
Tuesday, May 1, 2018
View article
-
Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S.
Tuesday, May 1, 2018
View article
